Wednesday, May 31, 2006

Can you just give me a pill?

The dreaded needle of today’s treatments may have an easier-to-swallow alternative.

An international study of oral cladribine has been expanded to sites in the United States. Cladribine inhibits immune reactions. The third phase is one of the largest MS trials ever.

A second oral possibility is Teriflunomide which modulates T-cells. A small trial included a handful of secondary progressive MSers among the 179 participants. A larger study is underway.

technorati tags: , , , , ,

No comments: